Researchers identify promising cancer drug target in prostate tumors
Tuesday, July 1, 2008 - 16:35
in Health & Medicine
Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" that drives runaway cell growth.In a letter appearing in an advanced online publication by the journal Nature, the researchers said the growth-stimulating molecule called p110beta — part of a cellular signaling network disrupted in several common cancers — is a promising target for novel cancer therapies designed to shut it down. The report's lead authors are Shidong Jia, Zhenning Liu, Sen Zhang, and Pixu Liu.read more
Read the whole article on Harvard Science
More from Harvard Science
Related
- Researchers identify promising cancer drug target in prostate tumorsThu, 26 Jun 2008, 11:29:44 EDT
- Blocking signaling protein prevents prostate cancer spread, Jefferson scientists findMon, 2 Jun 2008, 9:22:03 EDT
- Study raises questions about prostate cancer therapies targeting IGF-1Thu, 1 May 2008, 0:28:24 EDT
- Molecule plays early role in nonsmoking lung cancerMon, 27 Jul 2009, 13:29:50 EDT
- Researchers identify cancer-causing gene in many colon cancersSun, 14 Sep 2008, 13:21:59 EDT